Effect of pulmonary exacerbations on long-term lung function decline in cystic fibrosis

Abstract

Malignant mesothelioma is known for its dismal prognosis and poor response to conventional treatment. Chemotherapy with cisplatin–antifolate combinations recently showed promising response rates and prolonged survival in randomised trials.